Dolasetron News
Health Canada Endorsed Important Safety Information on Anzemet (Dolasetron Mesylate)
Cases of sustained supraventricular and ventricular arrhythmias, myocardial infarction and one case of fatal cardiac arrest have been reported in association with AnzemetŪ (dolasetron mesylate) use in both children and...
Prevention of Postoperative Nausea and Vomiting with Granisetron and Dolasetron in Relation to CYP2D6 Genotype
We investigated the efficacy of granisetron and dolasetron in preventing postoperative nausea and vomiting. Because the metabolism of the various antiemetic 5-hydroxytryptamine type 3 (5-HT3) antagonists involves different...
Organon to promote Sanofi-Aventis postoperative nausea drug
Organon USA, a business unit of Akzo Nobel, has entered into a distribution agreement for Sanofi-Aventis' Anzemet Injection for the treatment of postoperative nausea and/or vomiting.
Organon Enters into Distribution Agreement for Anzemet(R)
Roseland, N.J., Today Organon USA Inc., a business unit of Akzo Nobel NV, announced that they have entered into a distribution agreement for Anzemet(R) Injection (dolasetron mesylate injection) with Aventis Pharmaceuticals Inc.,...
Displaying results 6 to 9 out of 9